GL1X · GenesisL1 explorer

Research workbench

JAK3 in complex with a covalent EGFR inhibitor

Analyse JAK3 in complex with a covalent EGFR inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4V0G
Type
protein
Length
543 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase JAK3
EC
2.7.10.2
UniProt
P52333
Ligands
G9B
Pockets
4 · best druggability 0.70

Structure

x-ray diffraction · 2 distinct chains · 42% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein kinase JAK3 (EC 2.7.10.2)protein26942% helix, 21% strandP52333
BTyrosine-protein kinase JAK3 (EC 2.7.10.2)protein27441% helix, 18% strandP52333

Ligands and binding sites

  • G9B · N-[3-(2-{3-amino-6-[1-(1-methylpiperidin-4-yl)-1H-pyrazol-4-yl]pyrazin-2-yl}-1H-benzimidazol-1-yl)phenyl]propanamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16190.700.7848G9B
24570.670.7936G9B
34010.630.7840empty
43190.620.7927empty

Interfaces

1 interface between chains.

  • A–B · 741 Ų buried · 4 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 modified, 2 covalent (phosphorylation, covalent ligand).

Compared structures

  • 4V0G · JAK3 in complex with a covalent EGFR inhibitor · the same entry in another collection · chain A against A, TM-score 1.00
  • P52333 · AlphaFold monomer V2.0 prediction for tyrosine-protein kinase JAK3 (P52333) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.